Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
GoPower offers comprehensive portable solar energy solutions, designed to save you money and reduce your environmental impact. Their user-friendly solar panels eliminate the need for complex installations, allowing easy setup anywhere. Their portable solar power stations, providing up to 1000w/1280WH at 240v, are perfect for various applications such as home offices, garden rooms, boats, events, and more. With multiple output sockets and versatile charging options including solar panels and mains electricity, GoPower provides a greener and cost-effective energy alternative.
days to go:
Extended
investment:
£10,000
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Rype addresses the dilemma of choosing between expensive or low-quality office furniture that contributes to carbon emissions and waste. By remanufacturing high-quality used office furniture, Rype offers cost-effective solutions with 80% lower carbon emissions and waste, while creating local jobs. Their mission is to significantly reduce office carbon emissions and costs through sustainable, circular economy practices, including exclusive furniture ranges made from waste materials. Rype's comprehensive services encompass furniture sourcing, remanufacturing, and employing marginalized individuals, contributing to a more environmentally friendly and socially responsible approach to office furnishings.
days to go:
Extended
investment:
Withheld
Veluba is a zero-emission transport solution for London. It is an application-hailed and pedal-powered eco-cab service for Central London which aims to provide a faster and cheaper solution for its over-polluted and over-congested capital city. The company has 30 Veluba cabs ready to go with and have just launched their app. The vehicles are designed and driven with safety at the forefront and drivers are fully insured. Each Veluba® is provided with digital signage screens, giving prominent ad space, and the possibility for an additional revenue stream. Veluba aims to expand beyond the first depot to reach more of London and become a key part of the city’s growing eco-transport infrastructure. The investment will enable the company to employ additional drivers.
days to go:
Expired
investment:
£78,590
Arc's aim is to become the market leader in electrical recreational vehicles by using licensed battery automotive technology as the base. The company was born out of Jaguar Land Rover’s White Space. Since its pre-launch, the ‘Vector’ has attracted global interest with over 590 news articles covering its release across 55 countries. Arc also witnessed over 130 sales inquiries in relation to the limited 399 units which it is planning to produce. The company is on a mission of creating vehicles that challenge the environment while protecting it.
days to go:
Expired
investment:
£1,067,420
Track is a property and money managing app designed for homeowners. It is backed pre-seed by Pi Labs which is Europe's leading proptech VC. The company is run by an experienced management team with a previous exit. Through products like TrackPro, Track Digital Deed, and Track Home Improvement Loan, the company provides a drastically improved experience of homeowner finances, from AI-powered home valuations and seamless expenses tracking, to intelligent goal planning. With the proceeds, Track will accelerate growth and traction in 2020.
days to go:
Expired
investment:
£167,619
The Studio enable members to achieve results through sustainable, structured training. The Studio offer a whole range of sessions such as group classes, one-to-one personal training, spinning and yoga.
days to go:
Expired
investment:
£30,564
Centaur Robotics is redefining mobility for the 10% of the global population who require assistance to walk 400 meters. Representing a £7 billion global opportunity, the company offers a blend of convenient service and innovative two-wheeled vehicle design, catering to individuals and collaborating with international brands in sectors such as airlines, shopping centers, retirement living, hotels, and restaurants.
After a successful 2020 investment round, Centaur Robotics is currently seeking the final £65,000 of its seed equity round. This funding will facilitate pre-production market trials, design refinements, large-scale testing, and production expansion. With established commercial traction, the company aims for a full commercial launch by June 2024.
days to go:
Expired
investment:
£795,101
